Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Biotech

Navidea deploying MSLs in launch of new diagnostic agent

May 02, 2013

Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.
 

Business Briefs: Manhattan Research, KPMG, Scioderm and GSK

April 30, 2013

Health-seeking consumers continue social-media push; Scioderm scores FDA's "Breakthrough" designation for bullosa agent; and GSK files NDA for airway treatment.
 

Pharmas to biotechs: let's make a deal

April 25, 2013

Having finally accepted that external R&D is the future, big pharmas are snapping up earlier-stage biotechs and biologics, but they're not betting the farm on them, thanks to pre-nup-like earnout deals.
 

Data show Gilead's sofosbuvir has 'clean' safety profile

April 24, 2013

Phase III findings on sofosbuvir, released in a medical journal, suggest no cause for concern from a safety perspective.
 

Q&A: BIO's Jim Greenwood

April 22, 2013

BIO chief Jim Greenwood talks policy priorities and previews the group's International Convention, now underway in Chicago.
 

FDA says competing biologic ads both misled

April 07, 2010

One is a sales aid, and one is a consumer brochure, but both ads -- for CSL Behring's Zemaira and for Talecris' Prolastin -- are false or misleading, FDA said in a pair of untitled letters.
 

Biosimilars mean competition, not marketing oblivion, for biologic brands

March 23, 2010

Far from sapping promotional budgets, biosimilars could spur marketing by makers of follow-on and original biologic alike, experts say.
 

Generic Lovenox takes step closer to reality, analyst says

January 22, 2010

Sandoz, the generics division of Novartis, is soliciting pre-orders for Sanofi-Aventis blood thinner Lovenox—actions that seem to suggest generic approval of the megablockbuster may be coming soon, one analyst says.
 

Senate health bill pharma-friendly on biologics, price controls

November 19, 2009

The Senate health reform bill would maintain the ban on price controls in the Medicare prescription drug benefit and establish a 12-year data exclusivity period for biologics.
 

EMD Serono launches male fertility education campaign

June 17, 2009

EMD Serono is partnering with Men's Health Network on a patient education campaign aimed at raising awareness of male infertility.
 

Lilly looks homeward for communications chief

June 08, 2009

Lilly named former Indianapolis mayor Bart Peterson to lead its communications and corporate affairs functions.
 

Last chance to grab glory

June 04, 2009

If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
 

Biotech launches personalized cancer treatment website

June 02, 2009

Champions Biotechnology, a company offering personalized cancer data for patients and physicians, launched a new website: PersonalizedCancerTreatment.com.
 

Non-compliance, requests for generics on the rise, says survey

May 28, 2009

Physicians say patient compliance is getting worse, and they're hearing more requests for generic or OTC alternatives to prescribed medications as the economic malaise takes its toll, according to a PriMed survey.
 

Consider the 'reasonable consumer,' says FDA draft guidance

May 26, 2009

DTC drug and device marketers looking to steer clear of FDA ad reviewers should follow the "reasonable consumer standard" and consider the net impression their promotions make on the lay viewer, not just the particulars, FDA said in a draft guidance.
 

AMA ethics group rethinks CME funding

May 14, 2009

A pair of American Medical Association committee reports urges that industry-funded CME be put on a tighter leash, but they're a far cry from the ban on commercial support called for by the AMA's Council on Ethical and Judicial Affairs a year ago.
 

DTC spend set to slide, loyalty cards up, says survey

May 13, 2009

Marketers anticipate substantial cuts in DTC spend in 2009, according to a Cegedim Dendrite survey in which 58% of respondents said they'd cut consumer ad spend this year. Last year 28% said they'd cut back on consumer advertising.
 

Pfizer taps former Gore aide to lead policy efforts

May 12, 2009

Pfizer hired onetime Gore advisor turned healthcare think tanker Gregory Simon to head its global policy efforts as the industry gears up for a health reform fight in Washington.
 

Amylin slashes sales force by 35%

May 05, 2009

Amylin is cutting 200 sales positions -- around 35% of its sales force -- as it merges its specialty and primary care sales forces into a single organization targeting endocrinologists and diabetes-focused primary care physicians.
 

Pharma industry reputation gains, says Harris Interactive

April 29, 2009

It seems corporate reputation is countercyclical for pharmas, as well. The drug industry was the only sector to see appreciable gains in public perception from 2007 to 2008, according to Harris Interactive, posting its highest rating in five years as financial services firms and automakers displaced pharmas in the dregs of public esteem alongside tobacco.
 

IOM: quit gifts, reps, samples

April 28, 2009

Physicians and medical institutions should shun gifts, reps, samples and ghostwriting, said the Institute of Medicine's conflict of interest committee in its full recommendations.
 

J. Lo joins Sanofi for pertussis awareness ads

April 24, 2009

Sanofi Pasteur and the March of Dimes have recruited Jennifer Lopez to serve as the face of a whooping cough awareness campaign.
 

Genentech pulls Raptiva over PML risk

April 09, 2009

Genentech and FDA announced the withdrawal of psoriasis treatment Raptiva due to a risk of progressive multifocal leukoencephalopathy (PML), a rare and deadly viral brain infection.
 

DDMAC raps sponsored links for omission of risk info

April 06, 2009

The FDA's Division of Drug Marketing, Advertising and Communications slapped 14 drug companies with untitled letters for sponsored links on Google deemed violative because they omitted risk information.
 

Iowa Senate passes harsh gifts, data ban bill

March 20, 2009

Iowa's state Senate passed a healthcare bill containing some of the toughest restrictions on drug company contacts with physicians yet.
 

Roche to acquire Genentech

March 12, 2009

Roche will buy all remaining shares of Genentech at $95 dollars apiece, or $46.8 billion total, the companies announced in a joint statement. Prior to the deal, Roche held 56% of the company's shares.
 

Massachusetts antes up with tough transparency law

March 12, 2009

Massachusetts passed regulation governing drug and device company sales and marketing that the state's deputy counsel boasted is "the most stringent of the existing state laws" and "sets PhRMA and AdvaMed codes as the floor."
 

MedPAC calls for reporting of samples

March 03, 2009

An influential advisory board urged Congress to impose far-reaching transparency rules on payments to healthcare professionals and organizations interacting with the drug industry--including reporting samples, in part to aid counterdetailing efforts.
 

BIO punts on PhRMA physician interaction code

February 20, 2009

The Biotechnology Industry Organization (BIO) issued a statement calling on member companies to develop their own codes of conduct on interaction with physicians, but again stopped short of adopting the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals.
 

Millennium's Dunsire named HBA Woman of the Year

February 17, 2009

The Healthcare Businesswomen's Association named Millennium chief Dr. Deborah Dunsire as its 2009 Woman of the Year.
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising App Centers For Disease Control Clinical Trial Consumer COPD Diabetes DTC Elan FDA Generic Generic Drugs iPad Lymphoma Marketing & Communications Merck Mobile Obesity Oncology Patent Cliff Patient Advocacy Patients Regulatory